To test tumor-inhibitory effects of siRNA-mediated knockdown of GIPC1, NRP1 and NRP2 more rigorously in an in vivo model, we subcutaneously transplanted Colo357 cells into the both flanks of immunocompromised mice. The gene discussed is NRP1; the disease is neoplasm.